| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 70,940 | 71,132 | 67,603 | 75,291 | | Cost of Revenue | 37,744 | 36,669 | 35,696 | 43,905 | | | Gross Profit | 33,196 | 34,463 | 31,907 | 31,386 | | | Operating Expenses | | Research Development | 5,911 | 5,529 | 5,184 | 6,563 | | Selling General and Administrative | 19,142 | 19,615 | 19,916 | 16,525 | | Non Recurring | (1,153) |
-
| 1,153 |
-
| | Others | 3,523 | 3,570 | 3,501 | 3,671 | | | | Total Operating Expenses | 27,423 |
-
| 29,754 |
-
| | | | Operating Income or Loss | 5,773 | 5,749 | 2,153 | 4,627 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 37 | 48 | 58 | 46 | | Earnings Before Interest And Taxes | 5,810 | 5,797 | 2,211 | 4,673 | | Interest Expense | 543 | 627 | 699 | 1,197 | | Income Before Tax | 5,267 | 5,170 | 1,512 | 3,476 | | Income Tax Expense | 1,846 | 1,992 | 483 | 1,558 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,421 | 3,178 | 1,029 | 1,918 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,421 | 3,178 | 1,029 | 1,918 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,421 | $3,178 | $1,029 | $1,918 |
|
0.09% Nasdaq 
0.32%
Income Statement
